Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated  Deficit	Accumulated  Deficit Cumulative Effect, Period of Adoption, Adjustment	Cumulative Translation  Adjustments
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Beginning balance (in shares) at Dec. 31, 2021			68,126
Beginning balance at Dec. 31, 2021	$ 31,727		$ 68	$ 200,614	$ (168,953)		$ (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			6,297
Issuance of common stock, net of offering costs	7,747		$ 6	7,741
Issuance of restricted stock (in shares)			144
Share-based compensation	5,739			5,739
Translation adjustment	(1)						(1)
Net loss	(16,540)				(16,540)
Ending balance (in shares) at Dec. 31, 2022			74,567
Ending balance at Dec. 31, 2022	28,672		$ 74	214,094	(185,493)		(3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			414
Issuance of restricted stock	1		$ 1
Share-based compensation	4,751			4,751
Translation adjustment	(1)						(1)
Net loss	(4,938)				(4,938)
Ending balance (in shares) at Dec. 31, 2023			74,981
Ending balance at Dec. 31, 2023	$ 28,456	$ (29)	$ 75	$ 218,845	$ (190,460)	$ (29)	$ (4)